{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T03:49:04Z","timestamp":1792986544374,"version":"4.5.0"},"reference-count":80,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T00:00:00Z","timestamp":1651795200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,9,22]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Cardiorenal syndrome (CRS) is a complex disease in which the heart and kidneys are simultaneously affected, and subsequently, the malfunction of one organ promotes the deterioration of the other. Heart failure (HF) with preserved ejection fraction (HFpEF) is the most common form of HF. The pathophysiology of CRS is not well known and several mechanisms have been proposed. An elevation of central venous pressure seems to be one of the key points to consider, among others such as an increase in intraabdominal pressure. Several diagnostic tools have been identified to establish the diagnosis of CRS in patients with HFpEF. Currently, the availability of biomarkers of renal and cardiac injury, the use of pulmonary ultrasound, the monitoring of the size of the inferior vena cava and the study of the renal venous pattern offer a new dimension in accurately diagnosing and quantifying organ damage in CRS. Beyond the symptomatic treatment of congestion, until recently specific therapeutic tools for patients with CRS and HFpEF were not available. Interestingly, the development of new drugs such as the angiotensin\/neprilysin inhibitors and sodium-glucose cotransporter-2 (SGLT-2) inhibitors offer new therapeutic strategies with potential benefits in reduction of cardiorenal adverse outcomes in this population. Randomized clinical trials that focus on patients with HFpEF are currently ongoing to delineate optimal new treatments that may be able to modify their prognosis. In addition, multidisciplinary teamwork (nephrologist, cardiologist and nurse) is expected to decrease the number of visits and the rate of hospitalizations, with a subsequent patient benefit.<\/jats:p>","DOI":"10.1093\/ckj\/sfac133","type":"journal-article","created":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T15:15:57Z","timestamp":1651590957000},"page":"1807-1815","source":"Crossref","is-referenced-by-count":38,"title":["New aspects in cardiorenal syndrome and HFpEF"],"prefix":"10.1093","volume":"15","author":[{"given":"Ana Bel\u00e9n","family":"M\u00e9ndez","sequence":"first","affiliation":[{"name":"Cardiology Department, Vall d'Hebron University Hospital, Vall d'Hebron Research Institute (VHIR) , Barcelona , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Antonieta","family":"Azancot","sequence":"additional","affiliation":[{"name":"Nephrology Department, Vall d'Hebron University Hospital, Universitat Aut\u00f2noma de Barcelona, Nephrology and Kidney Transplant Research Group, Vall d'Hebron Research Institute (VHIR) , Barcelona , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4912-2343","authenticated-orcid":false,"given":"Aleix","family":"Olivella","sequence":"additional","affiliation":[{"name":"Cardiology Department, Vall d'Hebron University Hospital, Vall d'Hebron Research Institute (VHIR) , Barcelona , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Soler","sequence":"additional","affiliation":[{"name":"Nephrology Department, Vall d'Hebron University Hospital, Universitat Aut\u00f2noma de Barcelona, Nephrology and Kidney Transplant Research Group, Vall d'Hebron Research Institute (VHIR) , Barcelona , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,5,6]]},"reference":[{"key":"2022092209483540300_bib1","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/eurheartj\/ehp507","article-title":"Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative","volume":"31","author":"Ronco","year":"2010","journal-title":"Eur Heart J"},{"key":"2022092209483540300_bib2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/ckj\/sfv124","article-title":"Focus on renal congestion in heart failure","volume":"9","author":"Afsar","year":"2016","journal-title":"Clin Kidney J"},{"key":"2022092209483540300_bib3","first-page":"78","article-title":"Prevalence of chronic renal disease in Spain: Results of the EPIRCE study","volume":"30","author":"Gonz\u00e1lez","year":"2010","journal-title":"Nefrologia"},{"key":"2022092209483540300_bib4","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.nefro.2018.04.004","article-title":"Prevalencia de enfermedad renal cr\u00f3nica en Espa\u00f1a: impacto de la acumulaci\u00f3n de factores de riesgo cardiovascular","volume":"38","author":"Gorostidi","year":"2018","journal-title":"Nefrolog\u00eda"},{"key":"2022092209483540300_bib5","doi-asserted-by":"crossref","first-page":"e0158765","DOI":"10.1371\/journal.pone.0158765","article-title":"Global prevalence of chronic kidney disease\u2014a systematic review and meta-analysis","volume":"11","author":"Hill","year":"2016","journal-title":"PLoS One"},{"key":"2022092209483540300_bib6","first-page":"1048","article-title":"A single number for advocacy and communication\u2014Worldwide more than 850 million individuals have kidney diseases","volume-title":"Kidney Int","author":"Jager","year":"2019"},{"key":"2022092209483540300_bib7","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1681\/ASN.2014070714","article-title":"Cause of death in patients with reduced kidney function","volume":"26","author":"Thompson","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"2022092209483540300_bib8","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1161\/CIRCULATIONAHA.109.886473","article-title":"Cardiorenal syndrome: new perspectives","volume":"121","author":"Bock","year":"2010","journal-title":"Circulation"},{"key":"2022092209483540300_bib9","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/eurheartj\/eht386","article-title":"Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis","volume":"35","author":"Damman","year":"2014","journal-title":"Eur Heart J"},{"key":"2022092209483540300_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21037\/amj.2020.03.03","article-title":"Global epidemiology and future trends of heart failure","volume":"5","author":"Lippi","year":"2020","journal-title":"AME Med J"},{"key":"2022092209483540300_bib11","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1681\/ASN.2012020145","article-title":"Associations between kidney function and subclinical cardiac abnormalities in CKD","volume":"23","author":"Park","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"2022092209483540300_bib12","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1136\/heartjnl-2016-310794","article-title":"Heart failure in patients with kidney disease","volume":"103","author":"Tuegel","year":"2017","journal-title":"Heart"},{"key":"2022092209483540300_bib13","doi-asserted-by":"crossref","first-page":"A7","DOI":"10.1053\/j.ajkd.2016.12.004","article-title":"US Renal Data System 2016 Annual Data Report: Epidemiology of Kidney Disease in the United States","volume":"69","author":"Saran","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"2022092209483540300_bib14","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1046\/j.1525-139X.2003.160271.x","article-title":"Clinical epidemiology of cardiac disease in dialysis patients: left ventricular hypertrophy, ischemic heart disease, and cardiac failure","volume":"16","author":"Foley","year":"2003","journal-title":"Semin Dial"},{"key":"2022092209483540300_bib15","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1161\/CIRCULATIONAHA.105.580506","article-title":"Renal function as a predictor of outcome in a broad spectrum of patients with heart failure","volume":"113","author":"Hillege","year":"2006","journal-title":"Circulation"},{"key":"2022092209483540300_bib16","first-page":"421","article-title":"Cardiorenal syndrome caused by heart failure with preserved ejection fraction","volume":"24","author":"Lazzeri","year":"2011","journal-title":"Intern J Nephrol"},{"key":"2022092209483540300_bib17","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"2022092209483540300_bib18","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1161\/CIRCULATIONAHA.118.034646","article-title":"A simple, evidence-based approach to help guide diagnosis of heart failure with preserved ejection fraction","volume":"138","author":"Reddy","year":"2018","journal-title":"Circulation"},{"key":"2022092209483540300_bib19","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1093\/eurheartj\/ehz641","article-title":"How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)","volume":"40","author":"Pieske","year":"2019","journal-title":"Eur Heart J"},{"key":"2022092209483540300_bib20","first-page":"1","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"36","author":"Task","year":"2021","journal-title":"Eur Heart J"},{"key":"2022092209483540300_bib21","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ccl.2019.04.001","article-title":"Cardiorenal syndrome: pathophysiology","volume":"37","author":"Kumar","year":"2019","journal-title":"Cardiol Clin"},{"key":"2022092209483540300_bib22","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ijcard.2007.10.002","article-title":"Diastolic heart failure in the elderly: underlying mechanisms and clinical relevance","volume":"125","author":"McDonald","year":"2008","journal-title":"Int J Cardiol"},{"key":"2022092209483540300_bib23","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nrcardio.2014.83","article-title":"The pathophysiology of heart failure with preserved ejection fraction","volume":"11","author":"Borlaug","year":"2014","journal-title":"Nat Rev Cardiol"},{"key":"2022092209483540300_bib24","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1056\/NEJMoa032566","article-title":"Diastolic heart failure\u2014abnormalities in active relaxation and passive stiffness of the left ventricle","volume":"350","author":"Zile","year":"2004","journal-title":"N Engl J Med"},{"key":"2022092209483540300_bib25","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/ejhf.1050","article-title":"Acutely decompensated heart failure with preserved and reduced ejection fraction present with comparable haemodynamic congestion","volume":"20","author":"Van Aelst","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"2022092209483540300_bib26","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.jacc.2007.08.072","article-title":"Cardiorenal Interactions. Insights from the ESCAPE trial","volume":"51","author":"Nohria","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2022092209483540300_bib27","first-page":"589","article-title":"Importance of venous congestion for worsening of renal function in advanced decompensated heart failure","volume":"53","author":"Mullens","year":"2008","journal-title":"Eur J Heart Fail Suppl"},{"key":"2022092209483540300_bib28","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1172\/JCI101720","article-title":"Edema and decreased renal blood flow in patients with chronic congestive heart failure; evidence of forward failure as the primary cause of edema","volume":"25","author":"Merrill","year":"1946","journal-title":"J Clin Invest"},{"key":"2022092209483540300_bib29","doi-asserted-by":"crossref","first-page":"e840","DOI":"10.1161\/CIR.0000000000000664","article-title":"Cardiorenal syndrome: classification, pathophysiology, diagnosis, and treatment strategies: a scientific statement from the American Heart Association","volume":"139","author":"Rangaswami","year":"2019","journal-title":"Circulation"},{"key":"2022092209483540300_bib30","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.hlc.2016.02.022","article-title":"Role of renal oxidative stress in the pathogenesis of the cardiorenal syndrome","volume":"25","author":"Giam","year":"2016","journal-title":"Heart Lung Circ"},{"key":"2022092209483540300_bib31","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1093\/eurheartj\/ehy531","article-title":"Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction: pROMIS-HFpEF","volume":"39","author":"Shah","year":"2018","journal-title":"Eur Heart J"},{"key":"2022092209483540300_bib32","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s10741-018-09768-9","article-title":"Cardiorenal syndrome in heart failure with preserved ejection fraction\u2014an under-recognized clinical entity","volume":"24","author":"Agrawal","year":"2019","journal-title":"Heart Fail Rev"},{"key":"2022092209483540300_bib33","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1086\/690018","article-title":"Kidney dysfunction in patients with pulmonary arterial hypertension","volume":"7","author":"Nickel","year":"2017","journal-title":"Pulmonary Circulation"},{"key":"2022092209483540300_bib34","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1161\/CIRCULATIONAHA.106.632745","article-title":"Impaired chronotropic and vasodilator reserves limit exercise capacity in patients with heart failure and a preserved ejection fraction","volume":"114","author":"Borlaug","year":"2006","journal-title":"Circulation"},{"key":"2022092209483540300_bib35","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/clc.23345","article-title":"Beta-blockers withdrawal in patients with heart failure with preserved ejection fraction and chronotropic incompetence: effect on functional capacity rationale and study design of a prospective, randomized, controlled trial (The Preserve-HR trial)","volume":"43","author":"Palau","year":"2020","journal-title":"Clin Cardiol"},{"key":"2022092209483540300_bib36","first-page":"1","article-title":"Biomarkers in cardiorenal syndromes","volume":"2018","author":"Fu","year":"2018","journal-title":"Biomed Res Int"},{"key":"2022092209483540300_bib37","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.ejheart.2008.07.014","article-title":"State of the art: using natriuretic peptide levels in clinical practice","volume":"10","author":"Maisel","year":"2008","journal-title":"Eur J Heart Fail"},{"key":"2022092209483540300_bib38","first-page":"1","article-title":"Improving the diagnostic accuracy of acute myocardial infarction with the use of high-sensitive cardiac troponin T in different chronic kidney disease stages","volume":"7","author":"Yang","year":"2017","journal-title":"Sci Rep"},{"key":"2022092209483540300_bib39","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jchf.2016.06.007","article-title":"Carbohydrate Antigen-125\u2013Guided Therapy in Acute Heart Failure: CHANCE-HF: A Randomized Study","volume":"4","author":"N\u00fa\u00f1ez","year":"2016","journal-title":"JACC Heart Fail"},{"key":"2022092209483540300_bib40","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.medcli.2018.08.020","article-title":"Carbohydrate antigen 125 in heart failure. New era in the monitoring and control of treatment","volume":"152","author":"Ll\u00e0cer","year":"2019","journal-title":"Medicina Cl\u00ednica"},{"key":"2022092209483540300_bib41","doi-asserted-by":"crossref","first-page":"390","DOI":"10.2174\/1570161115666170404121619","article-title":"Relationship of high-sensitivity C-Reactive protein concentrations and systolic heart failure","volume":"15","author":"Kang","year":"2017","journal-title":"Curr Vasc Pharmacol"},{"key":"2022092209483540300_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12882-017-0624-4","article-title":"Association of baseline, longitudinal serum high-sensitive C-reactive protein and its change with mortality in peritoneal dialysis patients","volume":"18","author":"Li","year":"2017","journal-title":"BMC Nephrol"},{"key":"2022092209483540300_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0201836","article-title":"High-sensitivity C-reactive protein in heart failure with preserved ejection fraction","volume":"13","author":"DuBrock","year":"2018","journal-title":"PLoS One"},{"key":"2022092209483540300_bib44","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.cardfail.2014.05.013","article-title":"Biomarker predictors of cardiac hospitalization in chronic heart failure: a recurrent event analysis","volume":"20","author":"Vorovich","year":"2014","journal-title":"J Card Fail"},{"key":"2022092209483540300_bib45","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.amjcard.2010.09.011","article-title":"Usefulness of soluble concentrations of interleukin family member ST2 as predictor of mortality in patients with acutely decompensated heart failure relative to left ventricular ejection fraction","volume":"107","author":"Manzano-Fernndez","year":"2011","journal-title":"Am J Cardiol"},{"key":"2022092209483540300_bib46","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1161\/CIRCHEARTFAILURE.110.958223","article-title":"High-sensitivity ST2 for prediction of adverse outcomes in chronic heart failure","volume":"4","author":"Ky","year":"2011","journal-title":"Circ Heart Fail"},{"key":"2022092209483540300_bib47","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/3952526","article-title":"sST2 as a new biomarker of chronic kidney disease-induced cardiac remodeling: impact on risk prediction","volume":"2018","author":"Plawecki","year":"2018","journal-title":"Mediators Inflamm"},{"key":"2022092209483540300_bib48","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ijcard.2014.09.011","article-title":"Renal function largely influences Galectin-3 prognostic value in heart failure","volume":"177","author":"Zamora","year":"2014","journal-title":"Int J Cardiol"},{"key":"2022092209483540300_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/CIRCHEARTFAILURE.116.003804","article-title":"Plasma and cardiac galectin-3 in patients with heart failure reflects both inflammation and fibrosis: implications for its use as a biomarker","volume":"10","author":"Besler","year":"2017","journal-title":"Circ Heart Fail"},{"key":"2022092209483540300_bib50","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.clinbiochem.2006.10.026","article-title":"Diagnostic accuracy of cystatin C compared to serum creatinine for the estimation of renal dysfunction in adults and children\u2014A meta-analysis","volume":"40","author":"Roos","year":"2007","journal-title":"Clin Biochem"},{"key":"2022092209483540300_bib51","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1093\/eurheartj\/ehq293","article-title":"Markers of renal function and acute kidney injury in acute heart failure: definitions and impact on outcomes of the cardiorenal syndrome","volume":"31","author":"Lassus","year":"2010","journal-title":"Eur Heart J"},{"key":"2022092209483540300_bib52","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ijcard.2014.12.135","article-title":"Prognostic value of in-hospital change in cystatin C in patients with acutely decompensated heart failure and renal dysfunction","volume":"182","author":"Rafouli-Stergiou","year":"2015","journal-title":"Int J Cardiol"},{"key":"2022092209483540300_bib53","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1159\/000504084","article-title":"Prognostic value of cystatin C-derived estimated glomerular filtration rate in patients with acute heart failure","volume":"10","author":"Jang","year":"2020","journal-title":"Cardiorenal Med"},{"key":"2022092209483540300_bib54","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/eurjhf\/hfp024","article-title":"Cystatin C and NT-proBNP, a powerful combination of biomarkers for predicting cardiovascular mortality in elderly patients with heart failure: results from a 10-year study in primary care","volume":"11","author":"Alehagen","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"2022092209483540300_bib55","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.hrthm.2018.12.023","article-title":"Cardiorenal status using amino-terminal pro\u2013brain natriuretic peptide and cystatin C on cardiac resynchronization therapy outcomes: from the BIOCRT Study","volume":"16","author":"Truong","year":"2019","journal-title":"Heart Rhythm"},{"key":"2022092209483540300_bib56","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jchf.2013.08.001","article-title":"Biomarkers of acute kidney injury in chronic heart failure: what do the signals mean?","volume":"1","author":"Testani","year":"2013","journal-title":"JACC Heart Fail"},{"key":"2022092209483540300_bib57","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/nrcardio.2017.56","article-title":"Expert consensus document: echocardiography and lung ultrasonography for the assessment and management of acute heart failure","volume":"14","author":"Price","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"2022092209483540300_bib58","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ahj.2020.06.003","article-title":"A randomized controlled trial of lung ultrasound-guided therapy in heart failure (CLUSTER-HF study)","volume":"227","author":"Araiza-Garaygordobil","year":"2020","journal-title":"Am Heart J"},{"key":"2022092209483540300_bib59","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/ejhf.1604","article-title":"Lung ultrasound-guided treatment in ambulatory patients with heart failure: a randomized controlled clinical trial (LUS-HF study)","volume":"21","author":"Rivas-Lasarte","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"2022092209483540300_bib60","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1053\/j.ajkd.2017.10.009","article-title":"Use of lung ultrasound for the assessment of volume status in CKD","volume":"71","author":"Covic","year":"2018","journal-title":"Am J Kidney Dis"},{"key":"2022092209483540300_bib61","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1007\/s00134-009-1745-4","article-title":"Inferior vena cava collapsibility to guide fluid removal in slow continuous ultrafiltration: a pilot study","volume":"36","author":"Guiotto","year":"2010","journal-title":"Intensive Care Med"},{"key":"2022092209483540300_bib62","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.hfc.2019.08.010","article-title":"The cardiorenal syndrome in heart failure","volume":"16","author":"Costanzo","year":"2020","journal-title":"Heart Fail Clin"},{"key":"2022092209483540300_bib63","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1007\/s10554-014-0468-y","article-title":"Prognostic significance of dilated inferior vena cava in advanced decompensated heart failure","volume":"30","author":"Lee","year":"2014","journal-title":"Int J Cardiovasc Imaging"},{"key":"2022092209483540300_bib64","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ajem.2008.01.002","article-title":"Identification of congestive heart failure via respiratory variation of inferior vena cava diameter","volume":"27","author":"Blehar","year":"2009","journal-title":"Am J Emerg Med"},{"key":"2022092209483540300_bib65","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S0140-6736(11)60101-3","article-title":"Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial","volume":"377","author":"Abraham","year":"2011","journal-title":"Lancet North Am Ed"},{"key":"2022092209483540300_bib66","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jchf.2016.12.011","article-title":"A multisensor algorithm predicts heart failure events in patients with implanted devices: results from the MultiSENSE Study","volume":"5","author":"Boehmer","year":"2017","journal-title":"JACC Heart Fail"},{"key":"2022092209483540300_bib67","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1080\/17434440.2020.1791701","article-title":"Should we overcome the resistance to bioelectrical impedance in heart failure?","volume":"17","author":"Hankinson","year":"2020","journal-title":"Expert Rev Med Devices"},{"key":"2022092209483540300_bib68","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1093\/ndt\/gfn707","article-title":"The mortality risk of overhydration in haemodialysis patients","volume":"24","author":"Wizemann","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"2022092209483540300_bib69","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s40620-018-00567-x","article-title":"Renal intraparenchymal resistive index: the ultrasonographic answer to many clinical questions","volume":"32","author":"Di Nicol\u00f2","year":"2019","journal-title":"J Nephrol"},{"key":"2022092209483540300_bib70","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.jchf.2016.03.016","article-title":"Clinical implications of intrarenal hemodynamic evaluation by doppler ultrasonography in heart failure","volume":"4","author":"Iida","year":"2016","journal-title":"JACC Heart Fail"},{"key":"2022092209483540300_bib71","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.jchf.2017.05.006","article-title":"Intrarenal flow alterations during transition from euvolemia to intravascular volume expansion in heart failure patients","volume":"5","author":"Nijst","year":"2017","journal-title":"JACC Heart Fail"},{"key":"2022092209483540300_bib72","doi-asserted-by":"crossref","DOI":"10.1002\/ehf2.12362","article-title":"Intrarenal venous flow in cardiorenal syndrome: a shining light into the darkness","volume":"5","author":"de la Espriella-Juan","year":"2018","journal-title":"ESC Heart Failure"},{"key":"2022092209483540300_bib73","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1056\/NEJMoa1210357","article-title":"Ultrafiltration in decompensated heart failure with cardiorenal syndrome","volume":"367","author":"Bart","year":"2012","journal-title":"N Engl J Med"},{"key":"2022092209483540300_bib74","doi-asserted-by":"crossref","first-page":"e015752","DOI":"10.1161\/JAHA.119.015752","article-title":"Ultrafiltration in acute heart failure: implications of ejection fraction and early response to treatment from CARRESS-HF","volume":"9","author":"Fudim","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"2022092209483540300_bib75","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1177\/0896860819895198","article-title":"The use of peritoneal dialysis in heart failure: a systematic review","volume":"40","author":"Chionh","year":"2020","journal-title":"Perit Dial Int"},{"key":"2022092209483540300_bib76","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1908655","article-title":"Angiotensin-Neprilysin inhibition in heart failure with preserved ejection fraction","volume":"381","author":"Solomon","year":"2019","journal-title":"N Engl J Med"},{"key":"2022092209483540300_bib77","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N Engl J Med"},{"key":"2022092209483540300_bib78","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/ckj\/sfz070","article-title":"Canagliflozin and renal events in diabetes with established nephropathy clinical evaluation and study of diabetic nephropathy with atrasentan: what was learned about the treatment of diabetic kidney disease with canagliflozin and atrasentan?","volume":"12","author":"Fernandez-Fernandez","year":"2019","journal-title":"Clin Kidney J"},{"key":"2022092209483540300_bib79","first-page":"284","article-title":"Setting up a cardiorenal clinic. Consensus document of the Cardiorenal Working Groups of the Spanish Society of Cardiology and the Spanish Society of Nephrology","volume":"56","author":"de la Espriella","year":"2021","journal-title":"REC: CardioClinics"},{"key":"2022092209483540300_bib80","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.2215\/CJN.14180920","article-title":"Management of heart failure patient with CKD","volume":"16","author":"Banerjee","year":"2021","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ckj\/advance-article-pdf\/doi\/10.1093\/ckj\/sfac133\/45291863\/sfac133.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/15\/10\/1807\/45972191\/sfac133.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/15\/10\/1807\/45972191\/sfac133.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T05:52:31Z","timestamp":1663825951000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/article\/15\/10\/1807\/6581608"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,6]]},"references-count":80,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,5,6]]},"published-print":{"date-parts":[[2022,9,22]]}},"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfac133","relation":{},"ISSN":["2048-8505","2048-8513"],"issn-type":[{"value":"2048-8505","type":"print"},{"value":"2048-8513","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,10]]},"published":{"date-parts":[[2022,5,6]]}}}